Pannee Praditsuktavorn
Chulabhorn Hospital(TH)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, T-cell and Retrovirus Studies, Cutaneous lymphoproliferative disorders research, Viral-associated cancers and disorders, CNS Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Correction: Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors(2017)220 cited
- → THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors(2017)107 cited
- → Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma(2019)13 cited
- → Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma(2015)8 cited
- → Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group(2019)7 cited
- → Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry(2024)6 cited
- → Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group(2023)6 cited
- → Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry(2016)6 cited
- → A Matched-Pair Analysis of EPOCH Versus CHOP As Frontline Therapy for Nodal Peripheral T-Cell Lymphoma, Excluding ALK-Positive Anaplastic T-Cell Lymphoma: A Multicenter Experience in Thailand(2016)3 cited
- → Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group(2020)2 cited